Dongping Mo
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA and protein synthesis mechanisms
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Oncology 8
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Feng Yan (8 shared papers)Li Ping Tang (5 shared papers)Jian Xu (5 shared papers)Pan Jiang (3 shared papers)Yining Yang (4 shared papers)Shiyang Pan (4 shared papers)Ruihong Sun (2 shared papers)Bing Li (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Journal of Inflammation Research (2 papers)BMC Cancer (1 paper)Drug Resistance Updates (1 paper)Clinica Chimica Acta (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Dongping Mo
19 papers receiving 542 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 162
- Molecular Biology 276
- Oncology 95
- Reproductive Medicine 12
- Immunology 20
Countries citing papers authored by Dongping Mo
This map shows the geographic impact of Dongping Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongping Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongping Mo more than expected).
Fields of papers citing papers by Dongping Mo
This network shows the impact of papers produced by Dongping Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongping Mo. The network helps show where Dongping Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongping Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 133 | |
| 2 | 2021 | 51 | |
| 3 | 2014 | 48 | |
| 4 | 2020 | 47 | |
| 5 | 2017 | 41 | |
| 6 | 2015 | 37 | |
| 7 | 2019 | 32 | |
| 8 | 2021 | 28 | |
| 9 | 2018 | 26 | |
| 10 | 2024 | 18 | |
| 11 | 2025 | 18 | |
| 12 | 2018 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2023 | 12 | |
| 15 | 2024 | 11 | |
| 16 | 2024 | 8 | |
| 17 | 2015 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 0 |
About Dongping Mo
Dongping Mo is a scholar working on Cancer Research, Oncology, Molecular Biology, Biochemistry and Nephrology, having authored 21 papers that have together received 550 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Gastric Cancer Management and Outcomes (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Cancer Research (162 citations), Molecular Biology (276 citations), Oncology (95 citations), Reproductive Medicine (12 citations) and Immunology (20 citations). Dongping Mo has collaborated with scholars based in China and United States. Frequent co-authors include Feng Yan, Li Ping Tang, Jian Xu, Pan Jiang, Yining Yang, Shiyang Pan, Ruihong Sun, Bing Li, Xuelian Xiao and Fang He. Their work appears in journals such as Frontiers in Oncology, Journal of Inflammation Research, BMC Cancer, Drug Resistance Updates and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.